Patrick J. Muraca
23Patents
7h-index
1Co-inventors
55Inventor score
Filing activity: Apr 4, 1997 → Apr 13, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5994071A | Assessment of prostate cancer | Emerging Cross-Sectional Technologies | 77 | Expired |
| US8278034B2 | Methods of making frozen tissue microarrays | Chemistry; Metallurgy | 43 | Expired |
| USD530021S1 | Antibody protein analysis chip | General | 36 | Expired |
| US8685891B2 | Method and assay for determining FAS expression | Physics | 32 | Active |
| US7354725B2 | Kinase peptides and antibodies | Physics | 25 | Expired |
| US6534307B1 | Frozen tissue microarrayer | Emerging Cross-Sectional Technologies | 9 | Expired |
| USD473648S1 | Stylet | General | 9 | Expired |
| US6582967B2 | Method of forming a microarray from frozen tissue | Emerging Cross-Sectional Technologies | 7 | Expired |
| USD598548S1 | Stylet | General | 4 | Expired |
| US6716619B1 | Stylet for use with tissue microarrayer and molds | Physics | 3 | Expired |
| USD714959S1 | Beam dump assembly | General | 1 | Active |
| US8900820B2 | Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors | Physics | 1 | Active |
| US8088589B2 | Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors | Physics | 1 | Active |
| USD718800S1 | Lens mount | General | 1 | Active |
| US8129125B2 | Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors | Physics | 1 | Active |
| US9739781B2 | Anti-phospho-Akt antibodies | Physics | 0 | Active |
| US7897354B2 | Kinase peptides and antibodies | Physics | 0 | Active |
| US9732158B2 | Antibodies against fatty acid synthase | Chemistry; Metallurgy | 0 | Active |
| US8580926B2 | Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan | Physics | 0 | Active |
| US7763438B2 | Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan | Physics | 0 | Active |
| US9029512B2 | Anti-phospho-Akt antibodies | Physics | 0 | Active |
| US8729239B2 | Antibodies against fatty acid synthase | Chemistry; Metallurgy | 0 | Active |
| US9056919B2 | USP2a peptides and antibodies | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.